Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    10578485 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Effects of Lycopene on High Risk Prostatic Tissue
Conditions: Intraepithelial Prostatic Neoplasia;   Prostatic Neoplasms
Intervention: Drug: Lycopene 30 mg or Placebo

Indicates status has not been verified in more than two years